Michal Droppa

Cangrelor in cardiogenic shock and after cardiopulmonary resuscitation: A global, multicenter, matched pair analysis with oral P2Y12 inhibition from the IABP-SHOCK II trial

Michal Droppa, Muthiah Vaduganathan, Ramkumar Venkateswaran et al. · Resuscitation · 2019 · 55 citations

Oral P2y12 Inhibition, Cardiogenic Shock, Cardiopulmonary Resuscitation +7

Inhibitory mechanisms of very low–dose rivaroxaban in non–ST-elevation myocardial infarction

Oliver Borst, Patrick Münzer, Nada Alnaggar et al. · Blood Advances · 2018 · 43 citations · Full text

Evaluation of Clinical Risk Factors to Predict High On-Treatment Platelet Reactivity and Outcome in Patients with Stable Coronary Artery Disease (PREDICT-STABLE)

Michal Droppa, Dimitri Tschernow, Karin Müller et al. · PLoS ONE · 2015 · 40 citations · Full text

Impact of point-of-care testing for CYP2C19 on platelet inhibition in patients with acute coronary syndrome and early dual antiplatelet therapy in the emergency setting

Fabian Stimpfle, Athanasios Karathanos, Michal Droppa et al. · Thrombosis Research · 2014 · 34 citations

Thrombosis, Cardiovascular Disease, Blood Platelet +9

Comparison of Deep Sedation With General Anesthesia in Patients Undergoing Percutaneous Mitral Valve Repair

Johannes Patzelt, Miriam Ulrich, Harry Magunia et al. · Journal of the American Heart Association · 2017 · 34 citations · Full text